{'fraction_non_alphanumeric': 0.016791044776119403, 'fraction_numerical': 0.005597014925373134, 'mean_word_length': 5.469879518072289, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Chronic myelogenous leukemia in Hodgkin's disease: Immunofluorescence of cells

A patient with Hodgkin's disease is described who developed chronic myelogenous leukemia 8 1/2 years after the start of radiation therapy. This therapy was fractional and was administered to most of the patient's skeleton. The radiation was an important factor in the development of leukemia. The presence of positive reactions to the antileukemic fluorescent antibodies may be consistent with the hypothesis that viruses are concerned with human leukemia.